Blueberries Medical Corp Stock Fundamentals

BBRRF Stock  USD 0.01  0.0005  5.56%   
Blueberries Medical Corp fundamentals help investors to digest information that contributes to Blueberries Medical's financial success or failures. It also enables traders to predict the movement of Blueberries OTC Stock. The fundamental analysis module provides a way to measure Blueberries Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Blueberries Medical otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Blueberries Medical Corp OTC Stock Current Valuation Analysis

Blueberries Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Blueberries Medical Current Valuation

    
  3.89 M  
Most of Blueberries Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Blueberries Medical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Blueberries Medical Corp has a Current Valuation of 3.89 M. This is 99.97% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 99.98% higher than that of the company.

Blueberries Medical Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Blueberries Medical's current stock value. Our valuation model uses many indicators to compare Blueberries Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Blueberries Medical competition to find correlations between indicators driving Blueberries Medical's intrinsic value. More Info.
Blueberries Medical Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Blueberries Medical's earnings, one of the primary drivers of an investment's value.

Blueberries Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Blueberries Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Blueberries Medical could also be used in its relative valuation, which is a method of valuing Blueberries Medical by comparing valuation metrics of similar companies.
Blueberries Medical is currently under evaluation in current valuation category among its peers.

Blueberries Fundamentals

About Blueberries Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Blueberries Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Blueberries Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Blueberries Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Blueberries Medical Corp. engages in the growth, cultivation, development, production, and supply of medicinal cannabis and related products in Colombia. It offers medicinal-grade cannabis oil extracts and related products. BLUEBERRIES MEDICAL is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Other Information on Investing in Blueberries OTC Stock

Blueberries Medical financial ratios help investors to determine whether Blueberries OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Blueberries with respect to the benefits of owning Blueberries Medical security.